share_log

Greenbrier, Fate Therapeutics, AnaptysBio And Some Other Big Stocks Moving Lower On Friday

Greenbrier, Fate Therapeutics, AnaptysBio And Some Other Big Stocks Moving Lower On Friday

綠薔薇,命運治療,AaptysBio 和其他一些大型股票在星期五走低
Benzinga Real-time News ·  2023/01/07 00:22

U.S. stocks traded higher, with the Dow Jones gaining more than 500 points on Friday. Here are some big stocks recording losses in todayâ€s session.

美股走高,道瓊斯週五獲得超過 500 點。以下是一些大股票記錄在現金會話中虧損。

  • Fate Therapeutics, Inc. (NASDAQ:FATE) shares tumbled 62.2% to $4.16 after the company announced termination of its collaboration agreement with Janssen, pipeline prioritization, next-generation programs and key 2023 initiatives.
  • Atai Life Sciences N.V. (NASDAQ:ATAI) declined 41.3% to $1.5450 after the company announced Perception Neuroscience's Phase 2a clinical trial did not meet its primary endpoint.
  • AnaptysBio, Inc. (NASDAQ:ANAB) dropped 28.8% to $21.49 after the company announced portfolio update across best-in-class immune cell modulating antibodies. Raymond James downgraded AnaptysBio from Outperform to Market Perform.
  • AMTD Digital Inc. (NYSE:HKD) shares declined 24.5% to $22.54 after surging around 200% on Thursday.
  • Bed Bath & Beyond Inc. (NASDAQ:BBBY) dropped 16.9% to $1.4050 after dropping around 30% on Thursday. The company said it will miss its 10-Q filing deadline for the quarter ending Nov 26, 2022 and has also concluded that there is substantial doubt about its ability to continue as a going concern.
  • XPeng Inc. (NYSE:XPEV) fell 15% to $10.11.
  • The Greenbrier Companies, Inc. (NYSE:GBX) fell 14% to $30.00 after the company reported Q1 earnings results and issued guidance.
  • Niu Technologies (NASDAQ:NIU) dropped 13.8% to $5.23. Niu Technologies posted Q4 sales of 138,279 units.
  • iQIYI, Inc. (NASDAQ:IQ) fell 13.4% to $5.93.
  • Kura Sushi USA, Inc. (NASDAQ:KRUS) dropped 13% to $42.11 after the company reported worse-than-expected Q1 EPS and sales results.
  • Gorilla Technology Group Inc. (NASDAQ:GRRR) fell 12.6% to $8.55.
  • Astec Industries, Inc. (NASDAQ:ASTE) dropped 10.7% to $37.31 after the company announced CEO transition.
  • Waters Corporation (NYSE:WAT) declined 9.9% to $312.79. SVB Leerink maintained Waters with a Market Perform and raised the price target from $320 to $352.
  • NIO Inc. (NYSE:NIO) dropped 9.6% to $9.81. Shares of several Chinese-made EV companies traded lower following Tesla's decision to lower its Made-In-China vehicle prices in reaction to softness in demand and competitive pressure.
  • Silvergate Capital Corporation (NYSE:SI) dropped 9.5% to $11.37 after multiple firms downgraded the stock and lowered their respective price target.
  • AMTD IDEA Group (NYSE:AMTD) fell 8.6% to $1.9198 after climbing 28% on Thursday.
  • 命運治療, 公司. (NASDAQ: FATE) 在該公司宣布終止與揚森的合作協議、管道優先順序、下一代計畫和 2023 年關鍵計畫終止後,股價下跌 62.2% 至 4.16 美元。
  • 阿泰生命科學 N.V. (納斯達克:阿泰)在該公司宣布感知神經科學的 2a 期臨床試驗未達到其主要終點之後,下降了 41.3%,至 1.5450 美元。
  • 方生技股份有限公司 (納斯達克:ANAB)在該公司宣布了一流的免疫細胞調節抗體的投資組合更新後,下降了 28.8%,至 21.49 美元。雷蒙德·詹姆斯降級 AnaptysBio 從「跑贏大市場」到市場表現.
  • 尚乘數碼 (紐約證交所代號:港元) 股價下跌 24.5% 至 22.54 美元,在周四飆升約 200% 後。
  • 床浴 & 超越公司. 週四下跌 30% 左右後,下跌 16.9% 至 1.4050 美元。該公司表示,將錯過截至 2022 年 11 月 26 日的季度的 10-Q 提交截止日期,並得出結論,對其繼續作為一個持續關注的能力存在重大懷疑。
  • 新鵬股份有限公司 紐約證交所代碼:XPEV) 下跌 15% 至 10.11 美元。
  • 綠薔薇公司有限公司 紐約證券交易所代碼:GBX)在該公司公佈第一季度盈利業績並發布指引後,下跌 14% 至 30.00 美元。
  • 牛科技 納斯達克:牛)下跌 13.8% 至 5.23 美元。牛科技公佈了第四季度銷售 138,279 台。
  • 愛奇藝股份有限公司 納斯達克:智商)下跌 13.4%,至 5.93 美元。
  • 庫拉壽司美國有限公司 在該公司的第一季每股盈利和銷售業績差於預期之後,下跌 13% 至 42.11 美元。
  • 大猩猩科技集團有限公司 納斯達克:政府稅率:稅率)下跌 12.6%,至 8.55 美元。
  • 亞斯達克工業股份有限公司 (納斯達克:阿斯特)在公司宣布首席執行官過渡之後,下跌 10.7% 至 37.31 美元。
  • 沃特斯公司 紐約證券交易所代碼:瓦特質期貨)下跌 9.9% 至 312.79 美元。SVB 利林維持沃特斯市場表現,並將目標價格從 320 美元提高至 352 美元。
  • 尼歐股份有限公司 紐約證交所代碼:紐約證券交易所)下跌 9.6% 至 9.81 美元。由於 Tesla 決定降低中國製造車輛價格,以應對需求疲軟和競爭壓力的反應,幾家中國製造的電動汽車公司的股價走低。
  • 銀門資本 紐約證券交易所代碼:SI)在多家公司下調股票並降低了各自的價格目標後,下跌 9.5% 至 11.37 美元。
  • 尚乘理念集團 紐約證交所代號:尚乘)在周四上漲 28% 後下跌 8.6% 至 $1.9198。

Check This Out: Top 5 Tech And Telecom Stocks That May Plunge

看看這個: 5 大可能暴跌的科技和電信股

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論